Sanofi said on Tuesday that the Food and Drug Administration had approved a lotion to treat head lice after clinical trials, which compared it with a placebo.

The medication, called Sklice, whose active ingredient is ivermectin, an anti-parasite drug long taken orally, will be sold in the United States by Sanofi's vaccines division, Sanofi Pasteur U.S., the company said.